Skip to product information
VOTED #1 PEPTIDE STORE
In 2025

Tesamorelin

Tesamorelin

May reduce visceral fat andimprove metabolic markers

Studied for stimulating GH release in clinical populations


In stock, ready to ship
 

QUANTITY

Tesamorelin is a synthetic 44-amino-acid analogue of growth-hormone-releasing hormone (GHRH). It is designed to stimulate the body’s own release of growth hormone, which potentially influences metabolic and adipose tissue processes.

When administered subcutaneously, Tesamorelin can target visceral adipose tissue (VAT) and has been studied in specific clinical populations for its effects on fat distribution, lipid profiles and liver fat.

How does tesamorelin compare to other growth alternatives?

Tesamorelin works by mimicking the body’s natural GHRH. Instead of supplying growth hormone directly, it may encourage controlled, natural GH pulses from the pituitary gland. This is different from direct GH use, which bypasses the body’s normal rhythm.

Other metabolic peptides (for example, peptides that work on appetite or glucose pathways) are often researched for broad “weight loss.” Tesamorelin is more often studied for targeted redistribution of deep abdominal fat and regulation of fat quality, which may be relevant in body composition research rather than only scale weight.

When can users expect to see results?

In published research, early hormonal and biochemical shifts (like IGF-1 changes) can begin within the first month. Visible and measurable differences in visceral fat and abdominal contour tend to be observed over a longer window. Often around 2 to 3 months and beyond.

With continued use out to 6–12 months in controlled studies, reductions in visceral fat, improvements in fat quality, and supportive changes in metabolic markers have been observed. These changes generally depend on consistent protocol use, and effects may reverse if the compound is discontinued.

What types of weight loss does it work for?

  • Visceral adipose tissue (VAT) modulation
  • Liver fat / hepatic fat fraction and lipid handling
  • Cardiometabolic markers such as triglycerides and non-HDL cholesterol
  • Body composition and abdominal contour research
  • GH/IGF-1 pathway regulation and fat-cell quality

Quality & Testing

Every batch of Tesamorelin is independently tested by a certified third-party laboratory to verify purity, identity, and composition.

Each analysis is performed using advanced methods such as HPLC and Mass Spectrometry, ensuring the highest research-grade quality.

  • Verified Purity: Each batch is tested for peptide integrity and composition.
  • Third-Party Certified: Analysis is conducted by accredited laboratories with validated testing procedures.
  • Transparent Results: The corresponding Certificate of Analysis (COA) and analytical data can be viewed in the product images above.

All products from My Peptides Lab undergo strict handling, temperature control, and documentation to guarantee consistency and traceability from production to shipment.

Benefits

  • May support reduction of deep abdominal / visceral fat
  • May promote healthier fat-cell characteristics (“fat quality”)
  • Can potentially influence liver fat and lipid handling
  • May encourage balanced GH/IGF-1 activity and hormonal signaling
  • Possibly supports improved body composition and metabolic profile over tim

Tesamorelin

Regular price €89,99
Regular price €89,99 Sale price €199,99
SAVE 55% Sold out
View full details

What do Tesamorelin results look like?

  • 3 month results on Retatrutide

  • 9 month results on Retatrutide

  • 4 month results on Retratutide & Tesamolerin

  • 2 week results on Retatrutide

    Meet Revolutionary Peptides Powered By Science

    200+
    Scientific Studies Completed
    96%

    of participants experienced significant changes in their daily lifestyle

    "Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity."

    Reported that Tesamorelin not only reduced visceral fat, but also improved fat “quality,” meaning healthier adipose characteristics, not just less mass.

    pmc.nbci.nlm.nih.gov

    "Tesamorelin Reduces Visceral and Liver Fat in INSTI-treated Persons with Abdominal Adiposity."

    Described reductions in visceral adipose tissue and measurable decreases in liver fat fraction over a 12-month period of Tesamorelin administration.

    natap.org

    “Efficacy and Safety of Tesamorelin in People Receiving Modern Antiretroviral Therapy Regimens.”

    Concluded that Tesamorelin supported meaningful visceral fat reduction and improved key metabolic markers without major negative impact on glucose control.

    pmc.ncbi.nlm.nih.gov

    “Effect of Tesamorelin in People with HIV With and Without Dorsocervical Fat”

    This analysis found that Tesamorelin consistently reduced visceral adipose tissue (VAT), even across different fat distribution patterns.

    cambridge.org

    Before & After

    What Should I Expect From Consistent Use of Tesamorelin?

    1 Week

    The body may begin responding to Tesamorelin’s GHRH-like activity, supporting a natural increase in GH and IGF-1 signaling. Early adaptation can encourage smoother hormone balance and energy regulation at the cellular level.

    1 Month

    Preliminary metabolic adjustments may become more noticeable. Researchers have observed early shifts in fat-cell metabolism and smoother GH pulsation patterns, setting the foundation for visible compositional improvements.

    2 Months

    Imaging and clinical data suggest Tesamorelin can begin influencing visceral fat levels by this stage. Enhanced fat-cell activity and early signs of healthier tissue density may start to appear in controlled study environments.

    3 Months

    This phase often coincides with measurable changes in abdominal definition and overall fat-quality improvement. Subjects in research models also show signs of improved metabolic balance and lipid profile support.

    6 Months

    Research indicates that sustained Tesamorelin use over this period may result in consistent visceral fat reduction and continued improvement in adipose-tissue health. Metabolic function tends to appear more efficient as GH/IGF-1 regulation stabilizes.

    12 Months

    Longer studies demonstrate continued positive changes in body composition and overall metabolic environment. Tesamorelin may support the maintenance of these favorable outcomes over extended periods of consistent administration in research settings.

    Why take Tesamorelin?

    Visceral Fat Targeting

    May help reduce deep abdominal fat for a more balanced body composition.

    Liver-Fat Support

    Can support healthier liver-fat levels and improved metabolic performance.

    Hormone Axis Optimization

    May promote natural GH and IGF-1 rhythms for steady energy and recovery.

    Fat-Cell Quality

    Can encourage smaller, healthier fat cells that function more efficiently.

    Metabolic Health

    May aid lipid balance and overall cardiometabolic well-being.

    Consistent Progress

    Can support ongoing, sustainable body-composition improvements over time.

    Important Questions Answered by Professionals
    *Answered by independent medical researchers and licensed medicine doctors

    What is the total volume of your syringe?

    Select Peptide Vial Amount

    How much peptide do you want per dose?

    How much bacteriostatic water are you adding?

    For a dose of 1 mg draw the syringe to — units